Trocars

SUNY Upstate Medical University is seeking to procure Trocars and Related disposable Products through a Vizient contract pursuant to New York State Finance Law section 163 (3) (vi). The procurement specifically covers medical trocars, including products from the Endopath and Endopath Xcel product lines, with varying specifications such as lengths ranging from 65mm to 150mm, diameters from 2mm to 50mm, and different tip types including bladeless, dilating, and blunt. Vendors must be authorized to sell these trocars or demonstrate clinical equivalency, which requires providing free supporting clinical documentation, equipment for examination, demonstration, and trial. The procurement is open to all New York State counties, with the primary location being 750 East Adams St, Syracuse NY 13210. Interested vendors must email Rachel Hawthorne to discuss the procurement, with a strict requirement to comply with NYS Finance Law 139 j&k (Lobbying Law), which restricts communication to only the designated contact. The proposal submission deadline is March 25, 2025, and the contract term will match the duration of the Vizient contract.

The procurement is not designated as a Service-Disabled Veteran-Owned Set Aside, and there are no specific restrictions on the types of organizations that can respond. Johnson & Johnson is noted as a business entity that has been awarded an identical or substantially similar procurement contract within the past five years. Successful contractors will be required to submit valid and current NYS Workman's Compensation and Disability Forms. While no specific award value or budget range is explicitly stated, the procurement covers a comprehensive range of medical trocars and related disposable products across multiple product lines and specifications. The evaluation will primarily focus on meeting clinical performance standards, with vendors needing to demonstrate equivalency to the specified Endopath and Endopath Xcel product lines. Vendors must be prepared to provide extensive documentation and potentially allow for equipment trials to validate their product's suitability for the medical university's requirements.